For Instance, To Profit From Growing Demand In Canada, canopy Growth’s Is Developing The Brand Tweed And It’s Inked A Partnership With Cultural Icon Snoop Dog On His Leafs By Snoop.

Among the most intriguing of these companies are Canadian medical marijuana stocks Canopy Growth ( TSX:WEED )( NASDAQOTH:TWMJF ) and Aphria, Inc. Medical marijuana Canada’s already got a national medical marijuana market, and it could soon put in place a national market for recreational marijuana too. For instance, to profit from growing demand in Canada, Canopy Growth’s is developing the brand Tweed and it’s inked a partnership with cultural icon Snoop Dog on his Leafs by Snoop. So far, Canopy Growth’s sales are small, but they’re growing quickly. In Q4, unaudited revenue was $9.7 million Canadian, up from CAD$3.5 million the year before, and profit was CAD$0.02 per share. The company’s investments to expand its business, however, could mean profit swings wildly in the future, or that profits turn to losses. With a market cap of nearly $1 billion, investors may already be pricing in a lot of its potential growth. Instead, investors might want to consider biopharmaceutical companies that are working on marijuana medicine, such as GW Pharmaceuticals ( NASDAQ:GWPH ), a U.K. drugmaker. GW Pharmaceuticals is developing Epidiolex, a purified CBD that in scientifically controlled clinical trials has reduced seizures by about 40% in rare forms of childhood epilepsy.